Dr. Paul Calat is an oral and maxillofacial surgeon who founded Mid-Manhattan Oral Surgery in New York City. He earned his dental degree from Tufts University School of Dental Medicine and served as chief resident at Harlem Hospital Center. Dr. Calat has practiced oral surgery for about 24 years, treating patients from offices in Manhattan and Hoboken. He is an ambassador for The Breathe Institute and founded the Mid-Manhattan chapter of the Spear Study Club. His practice handles wisdom tooth removal, dental implants, bone grafting, and corrective jaw surgery for adults and teens across the city.
(212) 696-2677
36 West 44th Street, Suite 600A, New York, NY, 10036
Top3Doctors.com selected Dr. Paul Calat as a top oral and maxillofacial surgeon in New York City because of his long track record, his leadership roles, and the practice he built from the ground up. He earned his dental degree from Tufts University School of Dental Medicine and served as chief resident at Harlem Hospital Center before launching his own practice. Dr. Calat has worked as an oral surgeon for about 24 years and serves as an ambassador for The Breathe Institute. He also founded the Mid-Manhattan chapter of the Spear Study Club, a group dentists join to sharpen their clinical skills. That mix of hands on experience and ongoing education matters when patients trust someone with jaw surgery.
What sets Dr. Calat apart is the practice he runs out of Midtown Manhattan, Mid-Manhattan Oral Surgery. He treats patients needing wisdom tooth removal, dental implants, bone grafting, and corrective jaw surgery, and he also sees patients at a second office in Hoboken. Dr. Calat supports the Leukemia and Lymphoma Society outside of his clinical work. His practice has stayed independent for more than two decades, giving patients a steady point of contact instead of rotating through different surgeons. For these reasons, Top3Doctors.com proudly names Dr. Paul Calat among the top three oral and maxillofacial surgeons in New York City.
Top3doctors.com Copyright @2026